Published March 5, 2012 | Version v1
Journal article

Preoperative rectal cancer staging with phased-array MR

  • 1. Department of Diagnostic Radiology, University of Pisa, Via Roma 67, 56100-Pisa (Italy)
  • 2. Department of Colorectal Surgery, University of Pisa, Via Paradisa 2, Cisanello, 56100-Pisa (Italy)
  • 3. Department of Pathology, University of Pisa, Via Roma 67, 56100-Pisa (Italy)

Description

We retrospectively reviewed magnetic resonance (MR) images of 96 patients with diagnosis of rectal cancer to evaluate tumour stage (T stage), involvement of mesorectal fascia (MRF), and nodal metastasis (N stage). Our gold standard was histopathology. All studies were performed with 1.5-T MR system (Symphony; Siemens Medical System, Erlangen, Germany) by using a phased-array coil. Our population was subdivided into two groups: the first one, formed by patients at T1-T2-T3, N0, M0 stage, whose underwent MR before surgery; the second group included patients at Tx N1 M0 and T3-T4 Nx M0 stage, whose underwent preoperative MR before neoadjuvant chemoradiation therapy and again 4-6 wks after the end of the treatment for the re-staging of disease. Our gold standard was histopathology. MR showed 81% overall agreement with histological findings for T and N stage prediction; for T stage, this rate increased up to 95% for pts of group I (48/96), while for group II (48/96) it decreased to 75%. Preoperative MR prediction of histologically involved MRF resulted very accurate (sensitivity 100%; specificity 100%) also after chemoradiation (sensitivity 100%; specificity 67%). Phased-array MRI was able to clearly estimate the entire mesorectal fat and surrounding pelvic structures resulting the ideal technique for local preoperative rectal cancer staging

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-7-29; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310712

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
7
Journal Page Range
p. 29
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47061839
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FEDERAL REPUBLIC OF GERMANY; MAGNETIC RESONANCE; NEOPLASMS; NMR IMAGING; NUCLEAR INDUSTRY; PATIENTS; RECTUM
Descriptors DEC
BODY; DEVELOPED COUNTRIES; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; EUROPE; GASTROINTESTINAL TRACT; INDUSTRY; INTESTINES; LARGE INTESTINE; ORGANS; RESONANCE; WESTERN EUROPE

Optional Information

Copyright
Copyright (c)2012 Giusti et al
Notes
PMCID: PMC3310712; PUBLISHER-ID: 1748-717X-7-29; PMID: 22390136; OAI: oai:pubmedcentral.nih.gov:3310712; licensee BioMed Central Ltd.